- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Infantile onset lysosomal acid lipase deficiency
- Meeting Date: March 2022
- Public Summary Document (PSD) March 2022 PBAC Meeting - (PDF 709KB)
- Public Summary Document (PSD) March 2022 PBAC Meeting - (Word 145KB)
Sebelipase alfa – March 2022
Sebelipase alfa: Solution concentrate for I.V. infusion 20 mg in 10 mL; Kanuma®
Last updated
15 July 2022